SFD:NASDAQSmithfield Foods, Inc. Analysis
Data as of 2026-06-26 - not real-time
$25.12
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Smithfield Foods (SFD) is trading at $25.12, which sits roughly 24.8% above its discounted cash‑flow fair value of $19.56, indicating a material pricing premium. The stock’s trailing P/E of about 9.8 and forward P/E near 9.7 suggest a relatively cheap earnings multiple for a consumer‑defensive company. However, a dividend yield of 5.1% coupled with a modest payout ratio of 41% provides a tangible income cushion. Technical metrics show a neutral trend, with the 20‑day SMA ($25.77) just above the current price and the 200‑day SMA ($24.21) below, while the RSI of 44 points to neither overbought nor oversold conditions. The MACD histogram remains negative and the signal line is bearish, hinting at short‑term downside pressure. Volatility is elevated at 26.7% over the past 30 days, but beta is near zero (0.04), meaning the stock moves largely independent of broader market swings. Support sits at $24.38 and resistance at $27.09, framing a relatively tight trading range. The company delivers solid fundamentals: ROE of 15%, free cash flow of $630 M, and a debt‑to‑equity of 33%, indicating manageable leverage. Analyst consensus is bullish with a median target of $32, reflecting confidence in the defensive nature of the packaged‑foods sector. Market sentiment is in “Extreme Greed” territory (Fear‑Greed Index 88.5), which may be inflating price expectations.
Given the dividend attractiveness and defensive positioning, the stock remains appealing for income‑focused investors despite the short‑term valuation premium. The increasing volume trend supports the notion that market participants are actively trading the stock, which could amplify price moves. Geographic exposure to export markets such as China and Mexico adds diversification but also introduces moderate regulatory and currency considerations. Overall, the balance of solid cash generation, sustainable payout, and low systematic risk tilts the risk profile toward the lower‑medium end. Investors should weigh the current overvaluation against the steady dividend and defensive moat when shaping their time‑horizon strategies.
Given the dividend attractiveness and defensive positioning, the stock remains appealing for income‑focused investors despite the short‑term valuation premium. The increasing volume trend supports the notion that market participants are actively trading the stock, which could amplify price moves. Geographic exposure to export markets such as China and Mexico adds diversification but also introduces moderate regulatory and currency considerations. Overall, the balance of solid cash generation, sustainable payout, and low systematic risk tilts the risk profile toward the lower‑medium end. Investors should weigh the current overvaluation against the steady dividend and defensive moat when shaping their time‑horizon strategies.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD signal
- Price trading above DCF fair value
- Elevated short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong free cash flow
- Attractive dividend yield
- Defensive consumer sector
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustainable payout ratio
- Low beta indicating market independence
- Stable earnings growth
Key Metrics & Analysis
Financial Health
Revenue Growth0.80%
Profit Margin6.49%
P/E Ratio9.8
ROE14.95%
ROA7.29%
Debt/Equity33.30
P/B Ratio1.4
Op. Cash Flow$1.2B
Free Cash Flow$630.4M
Technical Analysis
TrendNeutral
RSI44.0
Support$24.38
Resistance$27.09
MA 20$25.77
MA 50$26.39
MA 200$24.21
MACDBearish
VolumeIncreasing
Fear & Greed Index88.55
Valuation
Fair Value$19.56
Target Price$31.36
Upside/Downside24.83%
GradeOvervalued
TypeValue
Dividend Yield5.12%
Risk Assessment
Beta0.04
Volatility26.75%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.